Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» secondary hyperparathyroidism
secondary hyperparathyroidism
FDA approves Amgen drug for secondary hyperparathyroidism
Yahoo/Reuters
Wed, 02/8/17 - 09:18 am
FDA
Amgen
secondary hyperparathyroidism
kidney disease
etelcalcetide
That big new hyperparathyroidism drug from Amgen? The FDA rejected it
Endpoints
Thu, 08/25/16 - 09:38 am
secondary hyperparathyroidism
Amgen
FDA
AMG416
Opko wins approval for kidney drug after manufacturing snag
BioPharma Dive
Thu, 06/23/16 - 08:13 pm
OPKO Health
Rayaldee
FDA
secondary hyperparathyroidism
kidney disease
FDA Accepts OPKO’s New Drug Application for Rayaldee
Yahoo
Wed, 07/29/15 - 10:10 am
FDA
OPKO Health
secondary hyperparathyroidism
Rayaldee
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Fierce Biotech
Thu, 02/26/15 - 10:26 am
Amgen
AMG416
Sensipar
secondary hyperparathyroidism
FDA grants tentative approval for Teva's Cinacalcet HCl Tablets ANDA
News-Medical
Sat, 05/15/10 - 01:05 pm
Teva Pharmaceuticals
FDA
Cinacalcet HCl
Sensipar
secondary hyperparathyroidism